Litcius/Paper detail

RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer

Arun Kumar Mahato, Yulia Sidorova

2020International Journal of Molecular Sciences72 citationsDOIOpen Access PDF

Abstract

Rearranged during transfection (RET) is the tyrosine kinase receptor that under normal circumstances interacts with ligand at the cell surface and mediates various essential roles in a variety of cellular processes such as proliferation, differentiation, survival, migration, and metabolism. RET plays a pivotal role in the development of both peripheral and central nervous systems. RET is expressed from early stages of embryogenesis and remains expressed throughout all life stages. Mutations either activating or inhibiting RET result in several aggressive diseases, namely cancer and Hirschsprung disease. However, the physiological ligand-dependent activation of RET receptor is important for the survival and maintenance of several neuronal populations, appetite, and weight gain control, thus providing an opportunity for the development of disease-modifying therapeutics against neurodegeneration and obesity. In this review, we describe the structure of RET, its signaling, and its role in both normal conditions as well as in several disorders. We highlight the differences in the signaling and outcomes of constitutive and ligand-induced RET activation. Finally, we review the data on recently developed small molecular weight RET agonists and their potential for the treatment of various diseases.

Topics & Concepts

NeurodegenerationReceptor tyrosine kinaseBiologySignal transductionTyrosine kinaseReceptorCancer researchCancerTrk receptorKinaseCell biologyDiseaseInternal medicineMedicineGeneticsNeurotrophic factorsNuclear Receptors and SignalingMicroRNA in disease regulationCircular RNAs in diseases
RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer | Litcius